Hermansky-Pudlak syndrome (HPS5) in a nonagenarian

J AAPOS. 2013 Jun;17(3):334-6. doi: 10.1016/j.jaapos.2013.02.002. Epub 2013 Apr 19.

Abstract

Hermansky-Pudlak syndrome (HPS) is an autosomal-recessive disorder clinically characterized by oculocutaneous albinism, bleeding diatheses, and lysosomal accumulation of ceroid lipofuscin, which in some cases may cause granulomatous colitis and pulmonary fibrosis. Any of these complications could result in a shortened life span for patients with HPS. We report a 92-year-old man with HPS 5 who, to our knowledge, is the oldest patient with HPS documented in the literature. This report highlights the importance of typing HPS to counsel patients regarding disease prognosis.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Albinism, Oculocutaneous / diagnosis
  • Carrier Proteins / genetics*
  • Frameshift Mutation*
  • Hemorrhage / diagnosis
  • Hermanski-Pudlak Syndrome / diagnosis
  • Hermanski-Pudlak Syndrome / genetics*
  • Humans
  • Male
  • Platelet Storage Pool Deficiency / diagnosis
  • Pulmonary Fibrosis / diagnosis
  • Visual Acuity

Substances

  • Carrier Proteins
  • HPS5 protein, human